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Background: Immunogenetic evidence indicates that cytotoxic T lymphocytes (CTLs) specific for the weak CTL
antigen HBZ limit HTLV-1 proviral load in vivo, whereas there is no clear relationship between the proviral load
and the frequency of CTLs specific for the immunodominant antigen Tax. In vivo, circulating HTLV-1-infected cells
express HBZ mRNA in contrast, Tax expression is typically low or undetectable. To elucidate the virus-suppressing
potential of CTLs targeting HBZ, we compared the ability of HBZ- and Tax-specific CTLs to lyse naturally-infected
cells, by co-incubating HBZ- and Tax-specific CTL clones with primary CD4+ T cells from HLA-matched HTLV-1-
infected donors. We quantified lysis of infected cells, and tested whether specific virus-induced host cell surface
molecules determine the susceptibility of infected cells to CTL-mediated lysis.
Results: Primary infected cells upregulated HLA-A*02, ICAM-1, Fas and TRAIL-R1/2 in concert with Tax expression,
forming efficient targets for both HTLV-1-specific CTLs and CTLs specific for an unrelated virus. We detected
expression of HBZ mRNA (spliced isoform) in both Tax-expressing and non-expressing infected cells, and the
HBZ26 ? 34 epitope was processed and presented by cells transfected with an HBZ expression plasmid. However,
when coincubated with primary cells, a high-avidity HBZ-specific CTL clone killed significantly fewer infected
cells than were killed by a Tax-specific CTL clone. Finally, incubation with Tax- or HBZ-specific CTLs resulted in a
significant decrease in the frequency of cells expressing high levels of HLA-A*02.
Conclusions: HTLV-1 gene expression in primary CD4+ T cells non-specifically increases susceptibility to CTL lysis.
Despite the presence of HBZ spliced-isoform mRNA, HBZ epitope presentation by primary cells is significantly less
efficient than that of Tax.
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Human T lymphotropic virus type-1 (HTLV-1) persists
in the host in dynamic equilibrium with the cytotoxic T
cell response. Typically, virus-specific CD8+ cytotoxic
lymphocytes (CTLs) in the peripheral blood of infected
individuals are abundant and chronically activated. We have
previously reported that circulating CTLs spontaneously kill* Correspondence: a.rowan@imperial.ac.uk
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unless otherwise stated.HTLV-1-infected autologous CD4+ cells when co-cultured
directly ex vivo [1], and the rate of CTL lysis of
virus-expressing cells is inversely proportional to the
proviral load [2,3], a clinical predictor of disease risk.
The program of viral gene expression in vivo plays an
important role determining which CTL epitopes are
protective in chronic infection. Two promoters in the
HTLV-1 provirus direct transcription from the viral
genome, one on each sense strand of the provirus. The
plus stand encodes the viral transactivating protein Tax
and other structural and non-structural proteins, and thehis is an Open Access article distributed under the terms of the Creative
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basic leucine zipper factor (HBZ), which is biologically
active as both RNA and protein [4,5]. Ex vivo, minimal
plus-strand expression is detectable in infected peripheral
blood mononuclear cells (PBMCs), whereas HBZ is
persistently expressed [6]. Recent work in our laboratory
has revealed that a typical infected individual possesses
tens of thousands of clones of infected cells, each clone
distinguished by its unique proviral integration site in the
genome [7,8]. The genomic environment of the provirus
influences both clone abundance in vivo and viral
plus-strand reactivation ex vivo [9]; however, it is not
known whether integration site influences expression
of HBZ, or how HBZ expression interacts with Tax
expression in naturally-infected cells.
The repertoire of viral epitopes exposed to CTL surveil-
lance is determined by an individual? s human leukocyte
antigen (HLA) genes, and HLA-A*0201 and Cw*08 are
associated with reduced proviral load and disease risk in
Kagoshima, Japan [10]. The ability of an individual ? s
HLA-alleles to bind peptides from HBZ has been
shown to correlate inversely with proviral load and
risk of HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) [11]. Despite its significant
protective potential, the binding affinity of HBZ peptides to
HLA class I molecules was found to be significantly weaker
than that of peptides from Tax, and the frequency of
HBZ-specific CD8+ T cells in peripheral blood was
extremely low [11,12], although the IL-2 secreting
HBZ-specific CD8+ T cells were more frequently detected
in individuals with a viral load of below 1% of PBMCs
[12]. In addition, HBZ protein is present at levels barely
detectable by western blot; inefficient polyadenylation and
transport of mRNA from the nucleus are thought to be
responsible for this low expression [4,13-15]. Because of
the low immunogenicity of HBZ, it has been difficult to
directly test the ability of primary infected PBMCs to
present HBZ to CTLs. Here, we therefore used HBZ- and
Tax-specific CTL clones restricted by HLA-A*0201, which
binds peptides from both HBZ and Tax with high affinity.
The aims of the present study were to quantify the
efficiency of presentation of Tax and HBZ epitopes to
CTLs by primary, naturally-infected cells, and to test the
hypothesis that the efficiency of CTL target formation is
determined by virus-induced expression of specific host
molecules on the cell surface.
Results
1. Plus strand gene expression is kinetically linked to
upregulation HLA-A*02, ICAM-1, Fas and TRAIL-
R1/2 on naturally infected CD4+ T cells
Initially, we characterised the phenotype of purified
CD4+ T cells from HTLV-infected donors, bothex vivo and over 24 h culture in vitro. Using flow
cytometry, we quantified expression of HLA-A*02,
and a marker of viral plus-strand gene expression,
Tax. In addition, we assayed expression of several
surface molecules selected on the basis that they (1)
are expressed by CD4+ T cells, (2) alter susceptibility
to CTL lysis and (3) have been described to be either
dysregulated in HTLV-1 infection, or induced by
HTLV-1 proteins. At time zero, 100% of CD4+ T cells
were HLA-A*02+. Tax protein was first detected after
8 h incubation (Figure 1A): subsequently, a population
of HLA-A*02high, Fashigh, ICAM-1highcells emerged
(Figure 1B,C, D). In a cohort of ACs (n = 7) and
individuals with HTLV-1-associated inflammatory
disease (n = 8), multiparameter flow cytometric
staining revealed that this population of cells
co-expressed Tax, and Tax+CD4+ cells consistently
expressed significantly higher levels of HLA-A*02,
ICAM-1 and Fas than did Tax−CD4+ cells from the
same donor (Figure 2). In comparison with ACs,
donors with inflammatory disorders had a significantly
higher proviral load (p = 0.009, Mann Whitney, two
tailed) and correspondingly a higher frequency of Tax-
expressing cells in the CD4+ population (p = 0.014,
Mann Whitney, two tailed), however, there were no
discernible differences in the phenotype of Tax-
expressing cells between the two groups of donors
(Additional file 1). Expression levels of HLA-A*02,
ICAM-1 and Fas on Tax+ cells were strongly corre-
lated with that of Tax protein in most individuals
(Additional file 2). Similarly, we observed that TRAIL-
R1/2 expression was moderately upregulated on
Tax+CD4+ cells (Figure 2A), and, in HLA A*02−
donors, the median intensity of HLA-ABC ex-
pression on Tax+ cells was greater than Tax− cells
(Additional file 3).
These results show that plus-strand-expressing
cells differ from uninfected cells in that they have
a greater potential to present antigen (increased
HLA class 1 expression), a greater ability to form
a stable immunological synapse (increased ICAM-1
expression), and are primed to receive signals
delivered via proapoptotic death receptors.
2. HBZ-SI expression is maintained in cells which
reactivate plus strand gene expression
Utilising the specific upregulation of ICAM-1 on
cells which reactivated Tax expression, we enriched
Tax+ cells and compared quantities of HBZ spliced
isoform (HBZ-SI) and Tax mRNA with Tax− cells
from the same donor. Per infected cell, Tax expression
in the ICAMhigh fraction was significantly higher than
observed in the ICAM-/low fraction (Figure 1E);
however, in contrast, levels of HBZ-SI mRNA did
not differ between the two fractions (Figure 1F),
%
Ta
x+
0 12 24
0
5
10
%
 IC
AM
-1
 +
0 12 24
0
50
100
M
FI
 F
as
0 12 24
0
15
30
M
FI
 H
LA
 A
*0
2
0 12 24
0
15
30
Tax-
Tax+
(A) (B)
(C)
Time (hours)
(D)
(E) (F)
Co
pi
es
 H
BZ
-S
I m
RN
A
/in
fe
ct
ed
 c
el
l
ICAM-1 -/low ICAM-1 +
1
10
100 p=0.2
Co
pi
es
 T
ax
 m
RN
A
/in
fe
ct
ed
 c
el
l
ICAM-1 -/low ICAM-1 +
10
100
1000 p=0.03
Figure 1 Expression of Tax, HBZ-SI, HLA-A*02, ICAM-1 and Fas by HTLV-1 infected primary CD4+ cells. (A-D) Upregulation of HLA-A*02,
ICAM-1 and Fas occurs subsequent to the appearance of detectable levels of intracellular Tax protein. Purified CD4+ cells from four infected
individuals (2 AC, circular symbols; 2 HAM, triangular symbols; two of which were HLA-A*02+) were cultured for 0-24 h. Surface molecules were
stained with antibodies specific for HLA-A*02, ICAM-1, Fas, and CD4. Subsequently, cells were stained intracellularly with a Tax-specific antibody
and analysed by flow cytometry. Values are expressed either as the percentage of CD4+ cells within the positive gate or as median fluorescence
intensity on CD4+ T cells. (E-F) Expression of HBZ-SI and Tax mRNA by infected cells. CD8 depleted PBMC from six donors (2 AC, circular symbols;
4 HAM/TSP, triangular symbols) were incubated for 16 h to allow for Tax expression and ICAM-1 upregulation. Cells were subsequently sorted on
the basis of ICAM-1 expression separating Tax+ (ICAM-1+) from Tax− (ICAM-1-/low) cells. Exact copy numbers of HBZ-SI mRNA and Tax mRNA were
quantified and expressed as number of copies per infected cell in each fraction. Statistics: ICAM+ vs. ICAM-1low/−, Wilcoxon matched pairs test,
two tailed. See Additional file 6 for donor characteristics.
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tion of Tax expression did not significantly reduce
levels of HBZ-SI mRNA in naturally infected cells.
3. Tax+CD4+ cells are resistant to Fas ligation-induced
apoptosis
We tested whether Fashigh Tax+CD4+ cells were
sensitive to apoptosis induction via the Fas
pathway. While 5 h incubation with anti-APO-1/
Protein A (100 ng-1 μg/ml) was sufficient to induce
phosphatidylserine exposure on the cell surface in
70-80% of Jurkat T cells (Figure 3), both Tax-
expressing and non-expressing primary cells (frominfected and uninfected donors) were resistant to
apoptosis induced in this manner. Thus, elevated
Fas expression in the first 24 h of viral gene
expression is unlikely to play a major role in
CTL-mediated lysis of infected cells. Tax+CD4+
cells had a higher viability than Tax−CD4+ cells
after 24 h in vitro culture (Figure 3), confirming
that HTLV-1 plus-strand-expressing cells have a
survival advantage in vitro, regardless of Fas/TRAIL-
R1/2 expression.
4. Tax+CD4+cells are killed more efficiently than Tax−CD4+
cells when pulsed with peptide and coincubated with
Figure 2 Tax+CD4+ cells express elevated levels of HLA-A*02, ICAM-1, Fas, and TRAIL-R1/2. Purified CD4+ cells from 15 infected individuals
(7 AC, 1 P, 7 HAM) were cultured for 24 h, after which the cell surface was stained with antibodies specific for HLA-A*02, ICAM-1, Fas, Trail-R1/2
and CD4. Subsequently, cells were stained for Tax protein and analysed by flow cytometry. (A) Staining of one representative individual? s CD4+
cells. Numbers indicate the percentage of cells in each quadrant. (B) Frequency and (C) intensity of surface protein expression on Tax+CD4+ (black
bars) and Tax−CD4+ (white bars) for 15 individuals. Statistics: Tax+ vs. Tax−, Wilcoxon matched pairs test, two tailed; * denotes p < 0.02, *** denotes
p≤ 0.0002. Bars denote the mean ? SEM. See Additional file 6 for donor characteristics.
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epitope
To determine the net outcome of the altered
phenotype of Tax+CD4+ cells, we directly
quantified the ability of CTLs specific for an
unrelated HLA-A*02-restricted Epstein Barr virus
(EBV) epitope to kill CD4+ T cells from HLA-A*02+
HTLV-1-infected donors. CD4+ cells which had
been cultured for 12 h to allow spontaneous viralgene expression were loaded with a peptide
(GLCTLVAML) derived from the EBV BMLF-1
protein and mixed with a BMLF-1-specific CTL
clone. After a further 12 h, we quantified the
surviving Tax+ and Tax−CD4+ T cells. The
results (Figure 4) show that the EBV-specific
CTLs preferentially killed Tax+CD4+ cells.
5. Tax- and HBZ-specific CTL clones used in this study
sensitively detect naturally processed epitopes
Figure 3 Infected and uninfected primary CD4+ T cells are
resistant to Fas-induced apoptosis. CD4+ T cells purified from
nine HTLV-1-infected individuals (4 AC, 4 HAM, 1 uveitis) and six
uninfected individuals were cultured overnight to allow Tax and Fas
expression. Jurkat T cells were included in parallel as a positive
control. Anti-Apo-1 and Protein A were added at the indicated
concentrations, and cultures were continued for a further 5 hours.
Apoptotic and necrotic cells were detected by a combination of
Annexin V staining and Live/deadTM viability dye. Statistical analysis
was performed using the Wilcoxon matched pairs test, two-tailed. Bars
denote mean ? SEM. See Additional file 6 for donor characteristics.
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Figure 4 Tax-expressing CD4+ cells are preferentially killed by
CTL when loaded with HLA-A*0201 restricted peptide. Purified
CD4+ cells from six HLA-A*02+ infected individuals (2 AC, 1 P, 3
HAM) were cultured for 12 h alone, to allow expression of viral
proteins and any accompanying changes in cellular phenotype.
BMLF-1 specific CTLs were introduced to the culture at an E:T ratio
of 1:1 with and without the indicated concentration of BMLF-1
peptide. After a further 12 h incubation, the Tax expression by
CD4+ cells was quantified by intracellular staining and flow cytometry.
Percentage specific killing for each population and culture condition
was calculated using the baseline frequency of Tax+CD4+ cells
detected in the absence of specific peptide, and absolute CD4+ cell
counts. Shaded symbols denote the frequency of Tax+ cells killed, open
symbols denote the frequency of Tax− cells killed for each donor.
Statistical analysis was performed using the Wilcoxon matched
pairs test, Tax+ vs Tax−, two-tailed. Bars denote mean ? SEM.
See Additional file 6 for donor characteristics.
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Tax and HBZ by naturally infected cells, we
characterised the CTL clones used in this study. The
Tax-specific CTL clone, derived from an infected
donor, was itself infected with HTLV-1, but did not
express detectable levels of Tax protein by flow cy-
tometry (Additional file 4). CTL sensitivity was
quantified by incubating a range of concentrations of
peptide with HLA-A*02+ T2 cells in the presence of
cognate CTLs (Figure 5A). At the saturating peptide
concentrations both clones killed approximately
70% of peptide-loaded targets. The HBZ-specific
CTL clone (HBZ-1) efficiently killed targets loaded
with low peptide concentrations (EC50: 2 nM), and
indeed was more sensitive than the Tax-specific
CTL clone (Tax-1, EC50: 40 nM). Therefore, any
observed reduction in the rate of killing of
naturally-infected cells by the HBZ-specific clone
was due to the level of epitope processing or presen-
tation by target cells, rather than lower CTL effi-
ciency. To confirm that the HBZ26 ? 34 epitope is
processed and presented naturally, we transfected
cells with an expression plasmid encoding full-
length HBZ (HBZ-IRES-GFP) or GFP alone [13]:
HBZ-transfected cells were selectively killed by
HBZ-1 CTLs (Figure 5B).
6. Primary Tax+CD4+ T cells are killed by Tax-specific
CTLs but not by HBZ-specific CTLsCD4+ T cells from HLA-A*0201+ HTLV-1-infected
individuals were cultured alone, or in the presence
of HBZ- or Tax-specific CTL clones. Because of
technical limitations in detecting HBZ protein in
PBMC by flow cytometry, we used Tax protein
staining as a surrogate to directly identify virus
expressing cells. Tax expression was quantified after
overnight incubation (Figure 6A), and a reduction in
the frequency of Tax+CD4+ T cells was interpreted
as lysis of Tax-expressing cells by CTLs. As an
equivalent amount of HBZ-SI mRNA was detectable
in both Tax+ and Tax− primary infected cells from
the same donor, we reasoned that any killing of
HBZ- expressing cells would also lead to a detectable
reduction in the frequency of Tax+ cells. After 24 h
in vitro culture, we estimate that a median of 14% of
infected cells were expressing detectable levels of
Tax protein (range 7-71%).
After incubation with Tax-specific CTLs, on average
83% of Tax-expressing primary cells were lysed
(Figure 6B). In addition, the median fluorescent
intensity (MFI) of Tax staining was significantly
reduced after incubation with Tax-specific CTLs
(Additional file 2), consistent with our previous
finding that cells expressing high levels of Tax
Figure 5 HBZ-1 efficiently recognises both naturally processed and exogenously loaded HBZ26 ? 34. (A) HBZ-1 detects its cognate epitope
with greater sensitivity than Tax-1. CFSE-labelled T2 cells were incubated with a range of concentrations of the HBZ26? 34 or Tax11? 19 peptides for
1 h. Where indicated, CTL clones HBZ-1 or Tax-1 were added at an E:T ratio of 3:1. After 6 h incubation, cells were fixed, and the absolute number
of CFSE+ cells present in each culture condition was determined by flow cytometry. These data are representative of three experiments performed in
duplicate. (B) HBZ26? 34 is processed and presented to CTLs. BLCL were transiently transfected with either an expression plasmid which encoded HBZ
and GFP, or GFP alone. Cells were incubated for 18 h to allow gene expression, peptide processing and presentation, after which HBZ-1 CTLs were
added at the indicated ratio. Absolute numbers of GFP-positive cells were quantified by flow cytometry. Results are representative of two experiments
performed in triplicate.
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HBZ-specific CTLs did not kill a significant number of
Tax-expressing cells; nor was any reduction in Tax MFI
observed. We conclude that presentation of HBZ26? 34
by naturally-infected cells from HLA-A*A02+
individuals was not sufficient to efficiently trigger
cytolytic functions at this E:T ratio.
7. Incubation with HBZ-specific CTLs selects against cells
which express high levels of HLA-A*0201
We quantified surface expression of HLA-A*02
after culturing primary CD4+ T cells alone, or in
the presence of the HTLV-specific CTL clones.
After co-incubation with either HBZ-specific or
Tax-specific CTLs, there was a significant reduction
in the median intensity of HLA-A*02 expression by
Tax+CD4+ cells (Figure 6C). In contrast, the level of
HLA-A*02 expression was unchanged on Tax−CD4+
cells when cultured in the presence of either of the
CTL clones (Figure 6C).
8. Competition between Tax11? 19 and HBZ26 ? 34 peptides
We hypothesized that Tax11 ? 19 could inhibit
presentation of HBZ26? 34 by competing for binding to
HLA-A*0201 (Figure 7A). At saturating concentrations
of HBZ26? 34 (2 uM), preincubation with Tax11? 19 had
no effect on lysis of BLCL by CTLs. However, when
the concentration of HBZ26? 34 was limiting (0.02- 0.2
uM), Tax11? 19 could inhibit CTL detection of HBZ,
but only when present in 10,000-fold molar excess. We
also quantified the frequency of CD8+ T cells specific
for the Tax11? 19 and HBZ26? 34 epitopes in each of the
donors in this study. IFN-γ-producing Tax11? 19 specific
CD8+ cells were observed in all individuals, whereas
no HBZ26? 34 specific CD8
+ cells were detected
(Figure 7B).Discussion
We observed that viral reactivation altered expression of
several molecules which modulate susceptibility to CTL
mediated lysis: HLA-A*02, ICAM-1, Fas, and TRAIL-R1/2
were upregulated on the surface of unstimulated primary
CD4+ T cells which expressed Tax. Whilst the absolute
number of infected cells varied with proviral load, no
significant differences in phenotype or susceptibility to lysis
were observed between Tax-expressing CD4+ cells from
ACs and those from individuals with HTLV-1-associated
inflammatory conditions.
Whilst HTLV-1 p12 has been shown to direct degradation
of MHC class 1 [16], this effect appears to be overridden by
viral reactivation and Tax expression. The means by which
HLA-A*02 expression is increased on Tax+CD4+ cells is
unclear: possible mechanisms include MHC-peptide
complex stabilisation by large quantities of high-affinity
viral epitopes [17], or direct induction of MHC gene
expression driven by virus proteins [18], T cell activation,
or cytokines such as interferons and TNF-α [19]. ICAM-1
expression has been extensively studied in HTLV-1 infec-
tion [20]; both Tax and p12 can transactivate the ICAM-1
gene [21-23], and cross-linking of ICAM-1 enhances
proviral expression [24]. In the virological synapse, the
interaction of LFA-1 on uninfected cells with ICAM-1 on
Tax+ infected cells induces cytoskeletal rearrangement
and directional assembly and budding of viral particles
[25,26]; the ICAM-1-LFA-1 interaction may also explain
why HTLV-1-specific CTLs are preferentially infected
with HTLV-1 [27]. In the immunological synapse, LFA-1
ligation enhances signalling from the T cell receptor in
CD8+ T cells [28,29] lowering the activation threshold for
effector functions. Since the absolute number of peptide-
HLA complexes and the stability of the immunological
Figure 6 Tax11? 19-specific but not HBZ26? 34-specific CTLs kill Tax-expressing primary cells efficiently. Purified CD4
+ cells from 7 AC
(circular symbols), 1 P (square symbols), 7 HAM (triangular symbols), were cultured for 24 h alone, or in the presence of Tax-1 or HBZ-1 at an E:T
ratio of 3:1. After incubation, surface and intracellular markers were stained and analysed by flow cytometry. (A) Tax staining for one representative
individual; (B) frequency of Tax expression; (C) intensity of HLA-A*0201 expression for 15 individuals in the presence or absence of CTL selection.
Statistics: Wilcoxon matched pairs test, two-tailed. NS = not significant. Differences observed were statistically significant regardless of whether the
outlier (HEZ) was included or excluded. Bars denote mean ? SEM. See Additional file 6 for donor characteristics.
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these results suggest that Tax expression lowers the
threshold for CTL-mediated lysis.
Fas ligand and TRAIL are contained within lytic gran-
ules of CTLs, and are exposed at the surface of CTL
during degranulation, inducing apoptosis through initi-
ation of the caspase cascade in target cells expressing
the death receptors Fas and TRAIL-R. Ex-vivo primary T
cells from uninfected donors are resistant to Fas-ligation-
induced apoptosis [31]. We hypothesised that the elevated
level of Fas expression by Tax+ cells might render
them susceptible to Fas-mediated apoptosis: however,
we observed that both Tax+ and Tax− primary cells from
infected donors were resistant to apoptosis induction with
an anti-Fas antibody. Interestingly, Tax+ CD4+ cells actu-
ally survived in vitro more frequently than Tax− cells fromthe same donor (Figure 3). There are conflicting reports in
the literature whether Tax exerts pro- or antiapototic
effects (reviewed in [32]), and although this subset of cells
was identified by virtue of their expression of Tax protein,
other viral proteins may be responsible for the observed
enhanced viability in vitro. Indeed, a recent report indi-
cates that HBZ can inhibit apoptosis induction by interfer-
ing with FoxO3A localisation and function [33]. It is
conceivable that viral proteins have differing effects on cell
survival, depending on the differentiation and activation
status of the host cell. Our data on primary cells agree
with observations that HTLV-1-infected T cell lines
express high levels of Fas, but are resistant to Fas-L-induced
apoptosis [34-36] and express FAP-1 (Fas inhibitor) [37].
Regardless of the observed resistance to Fas-induced
apoptosis, Tax expression increased the sensitivity of
Figure 7 Competition between Tax11? 19 and HBZ26? 34. (A) Tax11? 19
inhibits presentation of HBZ26? 34 under certain conditions. CFSE-labelled
BLCL were incubated with a range of concentrations of Tax11? 19 peptide
for 1 h. HBZ26? 34 peptide was subsequently added. After a further 1 h
culture, HBZ-1 CTLs were added at an E:T ratio of 3:1. After 6 h
incubation, cells were fixed, and the absolute number of CFSE+ cells
present in each culture condition was determined by flow cytometry.
These data are representative of two experiments performed in
duplicate. (B) Recall CTL responses to HBZ26? 34 and Tax11? 19. PBMC
depleted of CD4+ T cells were cultured either alone, or in the presence
of 2 uM Tax11? 19 or HBZ26? 34. The frequency of IFN-γ producing cells
was enumerated by Elispot. AC are represented by circular symbols;
P, square symbols and HAM/TSP, triangular symbols.
Rowan et al. Retrovirology 2014, 11:116 Page 8 of 12
http://www.retrovirology.com/content/11/1/116peptide-loaded CD4+ cells to lysis by CTLs specific for an
unrelated virus, EBV. Our observations were qualitatively
identical in donors who were asymptomatic, and those
with inflammatory conditions. Our findings are also in
agreement with those of Kurihara et al. who showed that
cultured PBMC from two patients with Adult T cell
Leukaemia/Lymphoma (ATL) stimulated stronger responses
than PBMCs from uninfected donors in a mixed lympho-
cyte reaction [38]. These changes in cellular phenotype were
only observed after in vitro culture, and were not detected
in fresh peripheral blood samples. Two possible explana-
tions exist: either plus-strand gene expression occurs rarelyin the peripheral blood, or virus-expressing cells are killed
much more efficiently in vivo than in vitro.
Our choice of the HLA-A*0201 as a prototype MHC
class I allele was influenced by several factors. Firstly,
HLA-A*0201 strongly binds ? and therefore efficiently pre-
sents ? epitopes from both Tax and HBZ. Secondly, HLA-
A*0201 is present in a high frequency of individuals in our
cohort of donors, allowing us to test enough donors to
generate statistically meaningful data. Thirdly, the
availability of well-characterised high-avidity CTL
clones facilitated direct comparison of the levels of
presentation of each epitope. Finally, the availability
of an HLA-A*02-specific antibody allowed us to quantify
the level of expression of the exact molecule presenting
the epitopes of interest (for further discussion, please
see Additional file 5).
In contrast to Tax-specific CTLs, HBZ-specific CTLs
were unable to kill large numbers of Tax-expressing
cells, despite the fact that they expressed HBZ-SI mRNA
and were highly susceptible to CTL lysis. HBZ-specific
CTLs killed cells transfected with full-length HBZ, exclud-
ing a defect in processing or presentation of this epitope.
Although HBZ-SI mRNA can be sequestered in the
nucleus, this does not automatically exclude it from CTL
surveillance, because recent evidence shows that peptides
translated in the nucleus are targeted to the MHC class 1
presentation pathway [39]. A reduction in median fluores-
cence intensity of HLA-A*02 expression was observed after
incubation with either the Tax-specific CTL clone or the
HBZ-specific clone. This observation suggests that the
HBZ epitope was effectively presented only by cells
expressing the highest levels of HLA-A*02, and that the
intensity of expression of HLA-A*0201 is more important
than the level of Tax expression in determining whether an
infected cell is susceptible to lysis by HBZ-specific CTL.
We conclude that the level of presentation of HBZ by
naturally-infected primary cells is limiting, even for an
efficient (high-avidity) CTL clone. Further evidence of the
poor immunogenicity of HBZ in vivo is the frequent lack of
a detectable recall response to this epitope in HLA-A*02+
donors. These data are in agreement with the fact that,
using HLA-A*02/HBZ26? 34 tetramers, Suemori et al. could
not detect CD8+ T cells specific for this particular epitope
in ATL patients [40].
Affinity-dependent competition of peptides for binding
to MHC class 1 is a potential confounding factor in
this analysis. Tax11 ? 19 has a very high affinity for the
peptide-binding groove of HLA-A*0201, and so it could
either displace or exclude other peptides with lower
affinity. However, a 10,000-fold molar excess of Tax11? 19
was required to inhibit detection of HBZ26? 34 by the
HBZ-specific clone. We conclude that such peptide com-
petition is unlikely to materially impair presentation of
HBZ epitopes in vivo.
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contrast to the immunogenetic evidence [11] that CTL
recognition of HBZ is associated with a reduction in
proviral load and the risk of the inflammatory disease
HAM/TSP. We propose that HBZ has evolved under CTL
immune selection pressure to minimise its immunogenicity
by reducing both the number and the class 1-binding
affinity of peptide epitopes [11], and by restricting
translation of HBZ mRNA, partly by retention in the
nucleus [15]. HBZ-specific CTLs may exert their protect-
ive effect either by shaping the clonal population early in
infection, or by applying a low but constant selection
pressure on infected cells which express only the HBZ
transcript in vivo.
Conclusions
Tax protein is not only a strong immunogen, but also
non-specifically increases susceptibility of the cell to
CTL-mediated lysis. The net outcome of viral plus-strand
gene expression will be determined by the balance
between the resulting virus propagation (by both
proliferation and de novo infection) and recognition
by CTLs. The optimal strategy for HTLV-1 is to
maintain persistent, low level expression of HBZ to
promote proliferation, coupled with intermittent inducible
expression of the highly immunogenic plus strand that is
required for virion production. It is likely that CTLs
specific for plus-strand antigens select and maintain a
population of infected cells with integration sites
compatible with this mode of gene expression.
Methods
Primary cells
All donors attended the National Centre for Human
Retrovirology (Imperial College Healthcare NHS
Trust, St Mary's Hospital, London), and donated
blood having given informed consent in accordance
with the Declaration of Helsinki, with approval of the UK
National Research Ethics Service (09/H0606/106). PBMC
were isolated from whole blood using Histopaque-1077
(Sigma) and cryopreserved in FCS (Invitrogen) with 10%
DMSO (Sigma). Where indicated, CD4+ cells were isolated
by positive selection using magnetic beads (Miltenyi
Biotech). Unless otherwise stated, cells were cultured
in RPMI-1640 (Sigma), 5% human AB serum (Invitrogen),
supplemented with 2 mM L-glutamine, 50 U/ml penicillin,
50 μg/ml streptomycin and 20 μg/ml DNAse (Sigma).
Genomic DNA was extracted using a DNeasy kit
(Qiagen), and proviral load was estimated as described in
Demontis et al. [41]. A 1/3 dilution series starting
from 5 ng/ul genomic DNA was prepared, and the num-
ber of copies of Tax (primer pair: SK43 5? -CGGATACC
CAGTCTACGTGT-3? and SK44 5? -GAGCCGATAACG
CGTCCATCG-3? ) and beta-globin (primer pair: BG84F5? -GCAAGGTGAACGTGGATG-3? and BG84R 5? -TAAG
GGTGGGAAAATTGACC-3? ) present were quantified
using FastSYBR mastermix (Life technologies) with
the standard Fast SYBRgreen thermal cycle protocol
on a QuantStudio 7 Flex real-time PCR system (Life
technologies). A patient-derived infected CD4+ clone
with a mapped single integrated provirus was used a
reference standard [42]. In total, donors consisted of
16 AC (PVL 0.5-21%, mean 8.3%), 1 individual with
polymyositis (P, PVL 21.6%), 1 individual with uveitis
(UV, PVL 2.2%), 15 individuals with HAM/TSP (PVL
0.5-26%, mean 12.1%) and six uninfected individuals. To
identify HLA-A*0201+ individuals, PCR-SSO HLA typing
was performed by the Anthony Nolan Trust. Donor
characteristics outlined in detail in Additional file 6.
CTL clones
The Tax-specific CTL clone (Tax-1) was generated by
limiting dilution cloning from an asymptomatic HTLV-1
carrier, and recognised the Tax11? 19 epitope (LLFGYPVYV)
in the context of HLA-A*0201. The HBZ-specific
CTL clone (HBZ-1), which recognises the HLA-A*0201-
restricted epitope HBZ-26? 34 (GLLSLEEEL) [40], were
generated in vitro from an uninfected, HLA-A*0201+
individual. HTLV-1 specific CTL clones were expanded by
stimulation once per week with autologous gamma-
irradiated B-LCL cells (5000 rad) with 1 uM cognate peptide
(ThinkPeptides). An EBV-specific CTL clone (3H9) (a
gift from Tao Dong), which recognises the HLA-A*0201-
restricted epitope GLCTLVAML, was expanded by
stimulation with gamma-irradiated (3000 rads) mixed
allogeneic PBMC and 30 μg/ml phytohemagglutinin (Roche)
once every two weeks. All CTL cultures were supplemented
twice weekly with 100 IU/ml IL-2 (Promocell).
HTLV-specific CTL lysis of primary infected CD4+ cells
CD4+ T cells from HLA-A*0201+ donors were cultured
for 24 h either alone or in the presence of Tax-specific or
HBZ-specific CTL clones at an effector:target (E:T) ratio
of 3:1, and samples were then taken for flow cytometric
analysis. Peptide-loaded HLA-A*0201-expressing T2 cells
were used to monitor killing efficiency of CTLs on
each day the experiment was performed. There was
undetectable nonspecific killing of unloaded targets at
the E:T ratio chosen (Additional file 2).
Flow cytometric analysis
Cells were washed once in PBS, stained for 20 min
with 0.25 μl/ml fixable live/dead blue viability stain
(Molecular Probes), then washed with FACS buffer
(PBS 7% normal goat serum). Surface molecules were
stained for 20 min at RT with mAbs specific for cell-surface
markers, as follows: CD4-Qdot605 (clone S3.5, Invitrogen),
CD8-AF700 (LT8, Serotec), HLA-A*02-PerCPCy5.5 (BB7.2,
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TRAIL-R2/CD262-APC (clone DJR-2-4, Biolegend),
ICAM-1/CD54-Pacific Blue (HA58, Biolegend), Fas/
CD95-PE (DX2, Biolegend). Cells were fixed and permea-
bilised using FoxP3 staining buffers (eBioscience), and
stained with anti-Tax AF488 (LT-4) for 25 min at RT. Cells
were washed, acquired using a BD LSR Fortessa, then
analysed using Kaluza software (Beckman Coulter).
Gating strategy is outlined in Additional file 7. We
tested for correlation of markers by extracting data
from the Tax+CD4+ population. Matched fluorescence
intensity readings for each cell analysed were tested
for correlation with spearman, using SPSS software.
Quantification of viral RNA in Tax+ and Tax− infected cells
PBMC depleted of CD8+ T cells were cultured for 16 h,
harvested and stained with 0.4 ug/ml anti-ICAM-1-PE
(Biolegend) then separated using anti-PE microbeads
(Miltenyi Biotech) according to the manufacturers
instructions. RNA was prepared using a ? PARIS ? RNA
extraction kit and reverse transcribed using the ? Vilo ?
kit (life technologies). HBZ-SI was amplified using the
primer pair 5? -GGACGCAGTTCAGGAGGCAC-3? and
5? -CCTCCAAGGATAATAGCCCG-3?, Tax with 5? -CCG
GCGCTGCTCTCATCCCGGT-3? and 5? -GGCCGAACA
TAGTCCCCCAGAG-3 ?, normalised to 18 s RNA de-
tected using 5 ? -GTAACCCGTTGAACCCCATT-3 ? and
5 ? -CCATCCAATCGGTAGTAGCG-3 ? with FastSYBR
mastermix on a QuantStudio flex7 system using the
fast SYBRgreen thermal cycling protocol. Exact copy
numbers was determined using a standard curve of the
relevant target cloned into the pGEM-T-easy vector
(Promega). In parallel, the proviral load of each fraction
was estimated, and Tax protein and ICAM-1 expression
was assayed by flow cytometry.
Apoptosis assay
Jurkat T cells or primary CD4+ T cells were cultured
at 1 ? 10 6 cells/ml for 16 h in RPMI 10% FCS,
20 μg/ml DNase. Anti-Apo-1 (anti-Fas) and Protein A
(0.1-1 μg/ml, gift from Min-Li Weber) were added and
the culture was continued for a further 5 h. Samples were
washed in PBS and stained with live/dead blue stain. Cells
were washed once in AnnexinV binding buffer (Biolegend)
then stained with anti-CD4-PeCy5 (Beckman Coulter)
and AnnexinV-PE (Biolegend) for 20 min at RT. The
cells were washed and fixed for 20 minutes with 2%
paraformaldehyde in AnnexinV binding buffer. Tax
staining was performed as described above. Gating
strategy is outlines in Additional file 8.
CTL lysis assay using BLCL or T2 cells
HLA-A*0201+ autologous BLCL [40] or the TAP deficient
lymphoblastic T2 cell line (a gift from Keith Gould) wereused to estimate CTL sensitivity and as a positive control
to monitor CTL performance in experiments assaying
CTL lysis of primary CD4+ T cells. Cell lines were main-
tained in RPMI 1640 supplemented with 10% FCS,
2 mM L-glutamine, 50 U/ml penicillin, and 50 μg/ml
streptomycin, seeded at a density of 1 ? 10 5 cells /ml and
fed or split twice weekly as required. Cells were stained
with CFSE (Molecular Probes), and 100,000 cells were
loaded with peptide for 1 h before the addition of CTLs.
Alternatively, 2 ? 10 6 BLCL were transfected with 2 μg
HBZ-GFP expression plasmid or empty vector control (a
gift from JM Mesnard [13]) using an Amaxa protocol (Kit
C, program Z001, Lonza) 18 h prior to co-culture with
CTLs. In every experiment, negative controls consisting of
BLCL with no CTLs, and BLCL with CTLs but no peptide
were included to quantify nonspecific killing. After 6 h
incubation at 37?C, one volume of 4% paraformaldehyde
was added to each tube, vortexed and incubated for
20 min to fix. Ten μl Countbright beads (Invitrogen) were
added to each tube before acquisition. The number of
cells surviving was calculated as follows:
cells in tube ? cells collected=beads collected? ? 
total beads added to the tube:
CTL lysis assay using EBV-peptide loaded CD4+ T cells
CD4+ T cells were cultured alone at a density of 1 x 106
cells/ml for 12 h. EBV-specific CTL clones were added
at an E:T ratio of 1:1, with or without EBV BMLF-1 pep-
tide. T cells were cultured for a further 12 h, then samples
were taken for flow cytometric analysis. After 30 min incu-
bation, cells were fixed by the addition of 1 volume 4%
paraformaldehyde, and the cells were enumerated as de-
scribed above. Tax, CD4 and CD8 were stained in parallel.
Median nonspecific CTL killing in this assay was 24%.
IFN-γ Elispot
Elispots were carried out as described in Kattan et al. [2]
using an IFN-γ Elispot kit purchased from Mabtech.
Additional files
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associated inflammatory disorders.
Additional file 2: Extra data from CTL killing experiment, and
correlations between expression of Tax, HLA A*02, ICAM-1 and Fas.
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